Market Pulse: Stocks edged in mixed territory as banks and big tech tread water amid rate chatter...
Archive - January 16, 2026
OCGN’s Game-Changer: Positive Phase 2 Data Unveiled!
Introduction Ocugen, Inc. (NASDAQ: OCGN) is a clinical-stage biotech focused on gene therapies for...
